Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
197
datasets available to search
ShareScore release 0.7.1
Dataset results
197 results for “BCMA”
A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT05860036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells
ClinicalTrials.gov study NCT03778346. IPD Sharing: UNDECIDED. Countries: 1. Publications: 11.
A Study of LCAR-B38M CAR-T Cells, a Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Chinese Participants With Relapsed or Refractory Multiple Myel
ClinicalTrials.gov study NCT03758417. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma
ClinicalTrials.gov study NCT05201118. IPD Sharing: NO. Countries: 1. Publications: 1.
Clinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MM
ClinicalTrials.gov study NCT03940833. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT05430945. IPD Sharing: NO. Countries: 1. Publications: 2.
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03145181. IPD Sharing: Not stated. Countries: 5. Publications: 13.
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma
ClinicalTrials.gov study NCT04133636. IPD Sharing: YES. Countries: 8. Publications: 1.
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
ClinicalTrials.gov study NCT03751293. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
ClinicalTrials.gov study NCT06717113. IPD Sharing: YES. Countries: 1. Publications: 3.
Nanobody-based Biepitope CAR-T Cells Targeting BCMA in the Treatment of R/RMM
ClinicalTrials.gov study NCT06503107. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)
ClinicalTrials.gov study NCT05509530. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Received Three or More Lines of Therapy
ClinicalTrials.gov study NCT05998928. IPD Sharing: NO. Countries: 1. Publications: 2.
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease
ClinicalTrials.gov study NCT07148791. IPD Sharing: NO. Countries: 1. Publications: 4.
Human BCMA Targeted T Cells Injection Therapy for BCMA-positive Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04003168. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Humanized BCMA-targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT04670055. IPD Sharing: NO. Countries: 1. Publications: 1.
CART-BCMA Cells for Multiple Myeloma
ClinicalTrials.gov study NCT02546167. IPD Sharing: Not stated. Countries: 1. Publications: 2.
BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma
ClinicalTrials.gov study NCT03093168. IPD Sharing: YES. Countries: 1. Publications: 1.
Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04447573. IPD Sharing: Not stated. Countries: 1. Publications: 1.
P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT04960579. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.